US2022062196A1PendingUtilityA1
Arginine Silicate For Periodontal Disease
Est. expiryMar 13, 2035(~8.7 yrs left)· nominal 20-yr term from priority
A61K 33/00A61K 9/0063A61K 31/047A61K 31/198
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods for treating and/or preventing periodontal disease with arginine silicate are disclosed. Methods may include the steps of identifying an individual in need of treatment for, or in need of prevention of, periodontal disease and administering an effective amount of an arginine-silicate complex to said individual. Arginine silicate may also be used to ameliorate one or more symptoms of periodontal disease. In some aspects, arginine silicate may be used to restore gum health and/or stop or reverse recession of the gums and/or the loss of gum tissue in the oral cavity.
Claims
exact text as granted — not AI-modified1 .- 17 . (canceled)
18 . A method of ameliorating gum tissue loss, comprising:
identifying an individual having receding gums; and administering an effective amount of an arginine silicate complex, wherein the amount is effective to stop or reverse gum tissue loss.
19 . The method of claim 18 , wherein the effective amount of the arginine-silicate complex is topically administered to the oral cavity.
20 . The method of claim 18 , wherein the arginine-silicate complex comprises arginine, silicate, and inositol.
21 . The method of claim 18 , wherein the arginine-silicate complex is formulated as a mouthwash.
22 . The method of claim 18 , wherein the identifying an individual having periodontal disease or symptoms thereof comprises physical examination by a dental hygienist, dentist, oral surgeon, orthodontist, or medical doctor.
23 . The method of claim 18 , wherein the effective amount of the arginine-silicate complex is topically administered to the oral cavity.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.